207 related articles for article (PubMed ID: 22447725)
1. Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration.
de Graaff E; Maat P; Hulsenboom E; van den Berg R; van den Bent M; Demmers J; Lugtenburg PJ; Hoogenraad CC; Sillevis Smitt P
Ann Neurol; 2012 Jun; 71(6):815-24. PubMed ID: 22447725
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to Delta/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma.
Greene M; Lai Y; Baella N; Dalmau J; Lancaster E
JAMA Neurol; 2014 Aug; 71(8):1003-8. PubMed ID: 24935874
[TBL] [Abstract][Full Text] [Related]
3. Standardized test for anti-Tr/DNER in patients with paraneoplastic cerebellar degeneration.
Probst C; Komorowski L; de Graaff E; van Coevorden-Hameete M; Rogemond V; Honnorat J; Sabeter L; Graus F; Jarius S; Voltz R; Wildemann B; Franciotta D; Blöcker IM; Schlumberger W; Stöcker W; Sillevis Smitt PA
Neurol Neuroimmunol Neuroinflamm; 2015 Apr; 2(2):e68. PubMed ID: 25745634
[TBL] [Abstract][Full Text] [Related]
4. The MAZ protein is an autoantigen of Hodgkin's disease and paraneoplastic cerebellar dysfunction.
Bataller L; Wade DF; Graus F; Rosenfeld MR; Dalmau J
Ann Neurol; 2003 Jan; 53(1):123-7. PubMed ID: 12509857
[TBL] [Abstract][Full Text] [Related]
5. Anti-Tr/DNER Antibody-Associated Cerebellar Ataxia: a Systematic Review.
Campana IG; Silva GD
Cerebellum; 2022 Dec; 21(6):1085-1091. PubMed ID: 34817790
[TBL] [Abstract][Full Text] [Related]
6. Probably anti-Tr associated paraneoplastic cerebellar degeneration as initial presentation of a squamous cell carcinoma of the lung.
Bruylant K; Crols R; Humbel RL; Appel B; De Deyn PP
Clin Neurol Neurosurg; 2006 Jun; 108(4):415-7. PubMed ID: 16644410
[TBL] [Abstract][Full Text] [Related]
7. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease.
Bernal F; Shams'ili S; Rojas I; Sanchez-Valle R; Saiz A; Dalmau J; Honnorat J; Sillevis Smitt P; Graus F
Neurology; 2003 Jan; 60(2):230-4. PubMed ID: 12552036
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic cerebellar degeneration associated with an onconeural antibody against creatine kinase, brain-type.
Tetsuka S; Tominaga K; Ohta E; Kuroiwa K; Sakashita E; Kasashima K; Hamamoto T; Namekawa M; Morita M; Natsui S; Morita T; Tanaka K; Takiyama Y; Nakano I; Endo H
J Neurol Sci; 2013 Dec; 335(1-2):48-57. PubMed ID: 24018129
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
[TBL] [Abstract][Full Text] [Related]
10. Anti-Ma-associated paraneoplastic cerebellar degeneration in a patient with nodular lymphocyte-predominant Hodgkin lymphoma: a case report.
Inui R; Saito K; Shimomura Y; Yamashita D; Kawamoto M; Ishikawa T
BMC Neurol; 2020 Sep; 20(1):355. PubMed ID: 32967629
[TBL] [Abstract][Full Text] [Related]
11. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():168. PubMed ID: 26377319
[TBL] [Abstract][Full Text] [Related]
12. [Paraneoplastic cerebellar degeneration].
Sakai K
Brain Nerve; 2010 Apr; 62(4):357-64. PubMed ID: 20420175
[TBL] [Abstract][Full Text] [Related]
13. TRIM9 and TRIM67 Are New Targets in Paraneoplastic Cerebellar Degeneration.
Do LD; Gupton SL; Tanji K; Bastien J; Brugière S; Couté Y; Quadrio I; Rogemond V; Fabien N; Desestret V; Honnorat J
Cerebellum; 2019 Apr; 18(2):245-254. PubMed ID: 30350014
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin Lymphoma With Diplopia and Nystagmus: A Paraneoplastic Cerebellar Degeneration With Ectopic Expression of DNER Antigen on Reed-Sternberg Cells.
Fiorelli N; Fraticelli S; Bonometti A; Diamanti L; Paoletti M; Franciotta D; Gotti M; Lucioni M; Paulli M; Arcaini L
Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):e124-e127. PubMed ID: 34782261
[No Abstract] [Full Text] [Related]
15. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
[TBL] [Abstract][Full Text] [Related]
16. Anti-Tr/DNER antibody-associated cerebellar ataxia: three rare cases report and literature review.
Cai Y; Liu J; Ren H; Shi F; Che J; Geng Q; Tan Y; Guan H; Di W
Neurol Sci; 2023 Jan; 44(1):397-403. PubMed ID: 36094774
[TBL] [Abstract][Full Text] [Related]
17. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
[TBL] [Abstract][Full Text] [Related]
18. Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration.
Finsterer J; Voigtländer T; Grisold W
J Neurol Sci; 2011 Sep; 308(1-2):139-41. PubMed ID: 21762925
[TBL] [Abstract][Full Text] [Related]
19. Polarized targeting of DNER into dendritic plasma membrane in hippocampal neurons depends on endocytosis.
Kurisu J; Fukuda T; Yokoyama S; Hirano T; Kengaku M
J Neurochem; 2010 Jun; 113(6):1598-610. PubMed ID: 20367751
[TBL] [Abstract][Full Text] [Related]
20. A case report of plasmapheresis in paraneoplastic cerebellar ataxia associated with anti-Tr antibody.
Taniguchi Y; Tanji C; Kawai T; Saito H; Marubayashi S; Yorioka N
Ther Apher Dial; 2006 Feb; 10(1):90-3. PubMed ID: 16556143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]